ILLUMINA, INC. business relationships
Companies named in ILLUMINA, INC.’s 10-K filed 2026-02-12, and public companies whose annual reports name ILLUMINA, INC.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 5.0 / 10
- AI naming
- 26 / 100 Top 4% in its category
- Agent readiness
- 0 / 100
- AI adoption
- 0 / 100
Named in ILLUMINA, INC.’s annual report 0
No company named in this filing matched a company in the map.
Companies whose annual reports name ILLUMINA, INC. 22
“Illumina is both a customer of the Company and a major supplier of the Company's reagents and capital equipment.” SEC filing
“...nally, some of these licensing agreements include royalties that would be payable on net sales of Galler i , and any future products, pursuant to existing agreements and licenses with Illumina, the Chinese University of Hong Kong, and other third parties in excess of minimum annual royalty payments.” SEC filing
“In the case of attempting to obtain an alternative supplier for Illumina, Madison, or Twist, replacement instruments and associated reagents, tubes, and panels that meet our quality control and performance requirements may not be immediately available.” SEC filing
“In June 2021, we entered into a supply agreement with Illumina to provide products and services that can be used for certain research and clinical activities, including certain sequencers, reagents, and other consumables for use with the Illumina sequencers, as well as service contracts for the main...” SEC filing
“| Illumina, Inc. | | Non-exclusive license to certain rights held by or licensed to Illumina to intellectual property relating to non-invasive prenatal screening and the Prequel test. | | We pay Illumina a royalty based on the volume of Prequel testing administered by us. | |” SEC filing
“our in vitro diagnostics partnership with Illumina.” SEC filing
“...RDIAN") study-in collaboration with New York-Presbyterian, Columbia University, New York State Department of Health and Illumina, Inc.-which is designed to assess whole genome sequencing to screen newborns for more conditions than those currently included in standard newborn screening in the United...” SEC filing
“We rely on a limited number of suppliers, including Illumina, Inc., Life Technologies Corporation, Twist Biosciences Corporation, Path-Tec LLC and Agilent Technologies. for certain laboratory reagents, as well as sequencers and other equipment and materials, which we use in our laboratory operations...” SEC filing
“In the event Illumina ceases or slows its production of, or is otherwise unwilling or unable to continue to supply the sequencer reagents necessary for and currently used in our business at or near current pricing, we may be required to purchase different reagents from Illumina or to purchase from a...” SEC filing
“...sales of SOMAmer-based next-generation sequencing library preparation kits, (ii) a license agreement, pursuant to which Illumina provided a specified license to us for the intellectual property relating to Single SOMAmers for potential development and commercialization of Single SOMAmer reagents for...” SEC filing
“SomaLogic had previously entered into a collaboration agreement with Illumina in December 2021 for the joint development and commercialization of co-branded kits combining Illumina's Next Generation Sequencing technology with SomaScan technology (as subsequently amended, the "Collaboration Agreement...” SEC filing
“We are aware that Illumina has required our licensees, in order to secure a supply agreement for the sequencers and reagents necessary to run NIPT under our cloud-based distribution model, to pay an additional fee for a license under the pooled intellectual property in jurisdictions in which Illumin...” SEC filing
“Furthermore, our sequencers, sourced from Illumina, as well as certain other reagents we use for Panorama and our other tests, are intended for research use only and are labeled as RUO.” SEC filing
“Supply Agreement with Illumina” SEC filing
“In the case of an alternative supplier for Illumina, for example, there can be no assurance that replacement sequencers and various associated reagents will be available or will meet our quality control and performance requirements for our laboratory operations.” SEC filing
“On May 4, 2018, the Company entered into a license agreement with Illumina, Inc., or the Illumina Agreement.” SEC filing
“We believe that there are relatively few suppliers other than Thermo Fisher, Roche, Illumina, Becton, Dickinson and Company and Qiagen N.V. that are currently capable of supplying the instruments, reagents and other supplies necessary for our current products and services.” SEC filing
“Labs currently recognizes revenues from collecting a royalty from Illumina,” SEC filing
“In particular, we rely on Illumina as the sole supplier of the next generation sequencers and associated reagents we use to perform our genetic tests and as the sole provider of maintenance and repair services for these sequencers; on Roche Holdings AG for certain laboratory equipment, supplies and...” SEC filing
“Separate from their instrumentation product lines, both Illumina and Thermo Fisher Scientific Inc., for example, currently market next-generation sequencing clinical oncology kits that are sold to customers who have bought and operate their respective sequencing instruments.” SEC filing
“In addition, our rights to certain technologies, including those of Illumina, are licensed to us on a non-exclusive basis.” SEC filing
“Our suppliers, including Illumina, could cease supplying these materials and equipment at any time, could increase the price of these materials or equipment (including the promotional pricing offered to us by Illumina for our 2022 VA MVP Agreement and certain other projects) or fail to provide us wi...” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.